We are live on ! Find out more
CLLS

Cellectis
CLLS

38 hedge funds and large institutions have $160M invested in Cellectis in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 38 → 38 (0)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

13% less capital invested

Capital invested by funds: $184M → $160M (-$24.5M)

43% less call options, than puts

Call options by funds: $8K | Put options by funds: $14K

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
10
Closed
5
Calls
$8K
Puts
$14K
Net Calls
-$6K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.55M
2
Deutsche Bank
Deutsche Bank
Germany
+$1.17M
3
GH
GAM Holding
Switzerland
+$1.03M
4
BIT
BlackRock Institutional Trust
California
+$455K
5
ACA
Avoro Capital Advisors
New York
+$418K

Top Sellers

Rank Fund Capital Flow
1
LCM
Landscape Capital Management
New Jersey
-$1.58M
2
AG
Artal Group
Luxembourg
-$1.57M
3
CWM
Cabot Wealth Management
Massachusetts
-$843K
4
TAM
Tocqueville Asset Management
New York
-$734K
5
CCP
Clough Capital Partners
Massachusetts
-$476K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$85M +$16.3K +623 +0%
CAM
2
Cormorant Asset Management
Massachusetts
$12M – – –
O
3
OrbiMed
New York
$8.43M – – –
TCM
4
Tekla Capital Management
Massachusetts
$7.47M – – –
Lazard Asset Management
5
Lazard Asset Management
New York
$6.87M +$265K +10,120 +4%
Franklin Resources
6
Franklin Resources
California
$5.87M – – –
Millennium Management
7
Millennium Management
New York
$4.38M +$187K +7,142 +4%
PA
8
Perceptive Advisors
New York
$4.32M -$105K -4,001 -2%
CCP
9
Clough Capital Partners
Massachusetts
$3.69M -$476K -18,200 -11%
AG
10
Artal Group
Luxembourg
$3.61M -$1.57M -60,000 -29%
A
11
Abingworth
United Kingdom
$2.41M – – –
UBS Group
12
UBS Group
Switzerland
$2.33M -$2.51K -96 -0.1%
Deutsche Bank
13
Deutsche Bank
Germany
$1.71M +$1.17M +44,878 +172%
Morgan Stanley
14
Morgan Stanley
New York
$1.56M +$1.55M +59,104 +1,035%
ACA
15
Avoro Capital Advisors
New York
$1.41M +$418K +16,000 +37%
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
$1.34M – – –
GH
17
GAM Holding
Switzerland
$1.31M +$1.03M +39,350 +259%
BBA
18
Baker Bros. Advisors
New York
$1.2M – – –
PI
19
Putnam Investments
Massachusetts
$963K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$726K -$78 -3 -0%
VIA
21
Vident Investment Advisory
Georgia
$608K – – –
BIT
22
BlackRock Institutional Trust
California
$419K +$455K +17,419 New
Bank of America
23
Bank of America
North Carolina
$393K +$6.75K +258 +2%
HighTower Advisors
24
HighTower Advisors
Illinois
$327K +$3.27K +125 +0.9%
Fiera Capital (Canada)
25
Fiera Capital (Canada)
Quebec, Canada
$288K -$132K -5,047 -30%
1
2

CLLS Hedge Fund Activity: Q3 2016 in Review

38 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2016, worth a combined $160M — down 13% from $184M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CLLS positions and 5 closed out — a net gain of 1 holder — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.55M. The largest seller was Landscape Capital Management, cutting an estimated $1.58M.

  • 38 institutional investors held Cellectis (CLLS) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $160M of Cellectis stock for Q3 2016, down 13% quarter-over-quarter.
  • 6 funds opened new Cellectis positions in Q3 2016 and 5 closed out, a net change of +1 holder.
  • The largest Cellectis buyer in Q3 2016 was Morgan Stanley, an estimated $1.55M added.
  • The largest Cellectis seller in Q3 2016 was Landscape Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q3 2016.